At Jefferson, Philadelphia’s largest academic medical center, we hosted a series of presentations, where institutional investors, key opinion leaders, and the CEOs and CSOs of life sciences companies shared their approach to tackling the most pressing problems in global health.
Innovative research is leading to breakthroughs in medicines, therapies, devices, and technologies which will define the future of healthcare. There will be new treatments capable of curing a myriad of illnesses, thus helping people to live longer, with less pain. Through careful investing, countless lives can be profoundly improved.
This highly-exclusive and carefully curated event was hosted at Thomas Jefferson University, a 193-year-old institution that is acting like a start-up – nimble, inventive, optimistic, eager to try something different or strike out in new directions. Jefferson has combined annual revenues exceeding $4.8 billion, more than 28,000 employees, 7,800 students, 6,000 physicians/practitioners and 4,000 faculty.
In the birthplace of American, this event was not just another healthcare conference, but the start of a revolution in healthcare.
